Active Ingredient(s): Metyrapone
FDA Approved: * December 4, 1961
Pharm Company: * NOVARTIS
Category: Diagnostic Aid

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Metopirone Overview

Metyrapone, sold under the brand name Metopirone, is a medication which is used in the diagnosis of adrenal insufficiency and occasionally in the treatment of Cushing's syndrome (hypercortisolism). Contents 1 Medical uses 2 Pharmacology 2.1 Pharmacodynamics 3 Chemistry 4 Research 5 See also 6 References Medical uses Metyrapone can be used in the diagnosis of adrenal insufficiency. Metyrapone 30mg/kg, maximum dose 3,000mg, is administered at midnight usually with a snack. The plasma ...

Read more Metopirone Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Metopirone Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Capsule: 250mg
  • Tablet: 250mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Metopirone: (1 result)

Sorted by National Drug Code
  • 76336-455 Metopirone 250 mg Oral Capsule by Hra Pharma

Other drugs which contain Metyrapone or a similar ingredient: (1 result)